Browse Pet Safety Reports
16,698 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,698 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,698 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jan 12, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Localised itching; Reddening of the skin | Outcome Unknown |
| Jan 12, 2017 | Human | Unknown | Gamithromycin 15% Solution For Injection | Injection site swelling; Loss of voluntary movement; Injection site pain | Outcome Unknown |
| Jan 10, 2017 | Human | Unknown | Selamectin | Generalised rash; Pruritus; Accidental exposure | Recovered/Normal |
| Jan 10, 2017 | Human | Unknown | Oclacitinib Maleate | Rash; Skin lump | Ongoing |
| Jan 9, 2017 | Human | Unknown | Tulathromycin | Injection site reaction NOS | Outcome Unknown |
| Jan 4, 2017 | Human | Unknown | Oclacitinib Maleate | Eczema; Skin lump; Burning sensation (skin); Pruritic rash; Skin irritation | Ongoing |
| Jan 4, 2017 | Human | Unknown | Enrofloxacin | Emesis; Accidental drug intake by child | Recovered/Normal |
| Jan 4, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Jan 3, 2017 | Human | Unknown | Tulathromycin | Injection site lesion; Bad taste; Injection site pain | Outcome Unknown |
| Jan 3, 2017 | Human | Unknown | Copper Naphthenate | Dry skin; Malodour; Smell disorder NOS; Application site skin discolouration | Outcome Unknown |
| Jan 3, 2017 | Human | Unknown | Oxytetracycline Dihydrate (Oxytetracy... | Abnormal behaviour NOS; Accidental exposure; No sign | Outcome Unknown |
| Dec 29, 2016 | Human | Unknown | Florfenicol/Terbinafine Hydrochloride... | Eye irritation; Eye tingling | Recovered/Normal |
| Dec 28, 2016 | Human | Unknown | Praziquantel; Emodepside | Bad taste; Accidental exposure | Recovered/Normal |
| Dec 27, 2016 | Human | Unknown | Oclacitinib Maleate | Other immune system disorder NOS; Pneumonia; Accidental exposure | Outcome Unknown |
| Dec 25, 2016 | Human | Unknown | Dinoprost Tromethamine | Injection site reaction NOS; Accidental exposure; No sign | Outcome Unknown |
| Dec 22, 2016 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Dispenser, Abnormal | Recovered/Normal |
| Dec 22, 2016 | Human | Unknown | Tulathromycin | Injection site erythema; Injection site oedema; Injection site reaction NOS | Outcome Unknown |
| Dec 22, 2016 | Human | Unknown | Polysulfated Glycosaminoglycan | Injection site pain | Recovered/Normal |
| Dec 19, 2016 | Human | Unknown | Cefovecin | Chest tightness; Lip disorder NOS; Localised itching; Injection site reaction... | Recovered/Normal |
| Dec 19, 2016 | Human | Unknown | Oclacitinib Maleate | Skin lesion NOS; Pruritus; Erythematous rash; Accidental exposure | Ongoing |
| Dec 14, 2016 | Human | Unknown | Tylosin | Bad taste | Recovered/Normal |
| Dec 13, 2016 | Human | Unknown | Trilostane | Miscarriage | Recovered with Sequela |
| Dec 13, 2016 | Human | Unknown | Imidacloprid; Moxidectin | Feeling anxious; Dyspnoea; Trembling; Pain NOS; Accidental exposure | Recovered/Normal |
| Dec 10, 2016 | Human | Unknown | Device: Electrosurgery | Burn | Outcome Unknown |
| Dec 8, 2016 | Human | Unknown | Moxidectin | Eye irritation | Recovered/Normal |
| Dec 8, 2016 | Human | Unknown | Imidacloprid; Moxidectin | Impaired vision; Pain NOS; Insomnia; Lethargy (see also Central nervous syste... | Outcome Unknown |
| Dec 6, 2016 | Human | Unknown | Tildipirosin Injectable | Injection site pain | Outcome Unknown |
| Dec 6, 2016 | Human | Unknown | Praziquantel; Emodepside | Application site irritation; Accidental exposure | Recovered/Normal |
| Dec 5, 2016 | Human | Unknown | Roxarsone | Burning mouth sensation; Nausea; Gastroenteritis; Dizziness; Headache | Recovered/Normal |
| Dec 5, 2016 | Human | Unknown | Fluralaner Spot-On Solution | Skin disorders NOS | Ongoing |
| Dec 5, 2016 | Human | Unknown | Fluralaner Spot-On Solution | Burning sensation (skin); Application site skin discolouration | Recovered/Normal |
| Dec 4, 2016 | Human | Unknown | Eprinomectin 5 Mg/Ml Pour-On Solution | Headache | Outcome Unknown |
| Dec 2, 2016 | Human | Unknown | Tresaderm Dermatological Solution | Stinging sensation in eye; Accidental exposure | Outcome Unknown |
| Dec 1, 2016 | Human | Unknown | Orbifloxacin Oral Suspension | Tooth disorder; Unclassifiable adverse event | Outcome Unknown |
| Dec 1, 2016 | Human | Unknown | Afoxolaner 28.3 Mg Chewable Tablets | Hives (see also 'Skin'); Itching; Sneezing | Outcome Unknown |
| Nov 30, 2016 | Human | Unknown | Fluralaner Spot-On Solution | Facial rash (For urticaria see Immune SOC) | Outcome Unknown |
| Nov 30, 2016 | Human | Unknown | Oclacitinib Maleate | Local swelling (not application site); Accidental exposure; Swollen feet | Outcome Unknown |
| Nov 28, 2016 | Human | Unknown | Tylosin | Injection site pain | Outcome Unknown |
| Nov 27, 2016 | Human | Unknown | Eprinomectin 5% Injection | Skin lesion NOS | Outcome Unknown |
| Nov 27, 2016 | Human | Unknown | Tilmicosin | Bad taste; Tingling sensation; Injection site swelling | Outcome Unknown |
| Nov 27, 2016 | Human | Unknown | Tildipirosin Injectable | Injection site bleeding | Outcome Unknown |
| Nov 26, 2016 | Human | Unknown | Imidacloprid; Moxidectin | Bad taste; Tongue paraesthesia | Recovered/Normal |
| Nov 23, 2016 | Human | Unknown | Tilmicosin | Eye pain; Accidental exposure | Recovered/Normal |
| Nov 23, 2016 | Human | Unknown | Ivermectin 10 Mg/Ml Solution For Inje... | Skin lesion NOS | Recovered/Normal |
| Nov 21, 2016 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Nov 20, 2016 | Human | Unknown | Selamectin | Hives (see also 'Skin'); Hives (see also 'Skin'); Hypertension; Wheezing; Dig... | Ongoing |
| Nov 18, 2016 | Human | Unknown | Device: Surgical Instruments | Burn | Outcome Unknown |
| Nov 18, 2016 | Human | Unknown | Florfenicol/Flunixin Inj-Triac | Injection site swelling | Ongoing |
| Nov 18, 2016 | Human | Unknown | Enrofloxacin | Bad taste; Joint pain | Recovered/Normal |
| Nov 17, 2016 | Human | Unknown | Fluralaner Spot-On Solution | Application site tingling; Application site reaction NOS; Product problem; Co... | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.